Crucial Challenges For U.S. FDA In China As Medical Trade Booms
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA Country Director in China Christopher Hickey highlights the agency’s expansion and cooperation with its peers in testimony to the U.S.-China Economic and Security Review Commission.